会员注册 | 登录 | 微信快捷登录 QQ登录 微博登录 | 帮助中心 人人文库renrendoc.com美如初恋!
站内搜索 百度文库

热门搜索: 直缝焊接机 矿井提升机 循环球式转向器图纸 机器人手爪发展史 管道机器人dwg 动平衡试验台设计

   首页 人人文库网 > 资源分类 > DOC文档下载

高压乳匀法制备中药固体脂质纳米粒.doc

  • 资源星级:
  • 资源大小:142.00KB   全文页数:12页
  • 资源格式: DOC        下载权限:注册会员/VIP会员
您还没有登陆,请先登录。登陆后即可下载此文档。
  合作网站登录: 微信快捷登录 支付宝快捷登录   QQ登录   微博登录
友情提示
2:本站资源不支持迅雷下载,请使用浏览器直接下载(不支持QQ浏览器)
3:本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰   

高压乳匀法制备中药固体脂质纳米粒.doc

高压乳匀法制备中药固体脂质纳米粒作者厉英超1董蕾2贾皑1苌新明1薛挥1西安交通大学医学院1第一附属医院消化内科,陕西西安7100612第二附属医院消化内科,陕西西安710004摘要目的采用高压乳匀法将中药有效成分包载于固体脂质纳米粒SLN,并研究制备的纳米粒的主要性质。方法选择水飞蓟宾SIL和汉防己甲素TET为模型药物,采用高压乳匀法将其分别包载于SLN。在电镜下观察其形态,以粒度分析仪和Zeta电位分析仪测定其粒径和Zeta电位,用葡聚糖凝胶柱层析法和HPLC测定其包封率和载药量,还观察了SLN的稳定性。结果高压乳匀法制备的SILSLN呈球状,形态规则,平均粒径为157±8nm,Zeta电位为35.36±2.68mV,包封率为95.64,载药量为4.63TETSLN呈片状存在,不规则,粒径较小,平均粒径为47±3nm,Zeta电位为32.99±2.54mV,包封率为97.82,载药量为4.76。SILSLN和TETSLN有较高稳定性。结论高压乳匀法适于制备包载中药的SLN。关键词水飞蓟宾汉防己甲素固体脂质纳米粒高压乳匀法中药现代化中图分类号R944文献标识码A文章编号16734254200605054104PreParationofsolidlipidnanoParticlesloadedwithtraditionalChinesemedicinebyhighpressurehomogenizationLIYingchao1DONGLei2JIAAi1CHANGXinming1XUEHui11DePartmentofGastroenterology,FirstAffiliatedHospital,MedicalCollegeofXianJiaotongUniversity,Xian710061,China2DePartmentofGastroenterology,SecondAffiliatedHospital,MedicalCollegeofXianJiaotongUniversity,Xian710004,ChinaAbstractObjectiveToinvestigatethepreParationofsolidlipidnanoParticlesSLNloadedwithtraditionalChinesemedicinesbyhighpressurehomogenization,andstudythephysicochemicalcharacteristicsoftheParticlesproducedbythismethod.MethodsThemodeltraditionalChinesemedicines,silibininSILandtetrandrineTET,wereincorporatedintoSLNseParatelybyhighpressurehomogenization.TransmissionelectronmicroscopewasemployedtostudytheshapeoftheParticles.ParticlecharacterizationsystemandzetapotentialanalyzerwereusedtostudythediameterandzetapotentialofSLNinthesuspension.Theentrapmentefficiencyanddrugloadingweredeterminedwiththesephadexgelchromatographyandhighperformanceliquidchromatography.ThestabilityofSLNwasalsostudied.ResultsTheSILSLNspreParedbyhighpressurehomogenizationweresphericalandregular.ThemeandiameterandzetapotentialofSILSLNindistilledwaterwere157±8nmand35.36±2.68mV,respectively.Theentrapmentefficiencywas95.64,andthedrugloadingwas4.63.TheTETSLNwasplateletshaped,irregularandsmaller.ThemeandiameterandzetapotentialofTETSLNwere47±3nmand32.99±2.54mV,respectively,withdrugloadingof4.76,andupto97.82ofTETwasincorporated.SILSLNandTETSLNhadgoodstability.ConclusionHighpressurehomogenizationisfeasibleforpreParingSLNloadedwithtraditionalChinesemedicines.KeywordssilibinintetrandrinesolidlipidnanoParticleshighpressurehomogenizationtraditionalChinesemedicinesSupportedbyScienceandTechnologyProjectofXianCityGG04133.LIYingchao1974,PhD,attendingphysician,specializedinpharmaceuticalresearchofliverfibrosis,Tel02985324001,Emaill_163.comCorrespondingauthorDONGLei,medicalprofessor,Tel0298727693629368,Emaildonglei4488sohu.comSolidlipidnanoParticlesSLNsareParticlesmadefromsolidlipidswithameandiameterofapproximately50to1000nmtoserveasanalternativecolloidalcarriersystemforcontrolleddrugdelivery1.ComParedwithotherParticulatecarriersSLNhasseveraladvantagesfordrugdeliverysuchasitsgoodbiocomPatibility2,biodegradability3,highbioavailability4,andeffectstargetingtheliverandspleen.Inrecentyears,markedlyincreasingstudiesonSLNhavebeenreported,especiallywiththemethodofhighpressurehomogenization5.Nevertheless,onlyafewinvestigationshavebeenconductedinregardwiththeincorporationofeffectivecomponentsoftraditionalChinesemedicinesintoSLN.SilymarinisapurifiedextractfromthemilkthistleSilybummarianumL.Gaertn,whichiscomposedofamixtureof4isomericflavonolignans,namelysilibininorsilybin,SIL,isosilibinin,silidianinandsilychristin.SIL,whichconstitutes6070ofthesilymarinmixture,hasbeenidentifiedasthemajoractivecomponent6.TetrandrineTETisabisbenzylisoquinolinealkaloidextractedfromthetraditionalChinesemedicinalherbRadixstephaniatetrandrae.SILandTETpossesswidespectrumsofpharmacologicalactivities7891011.ThesetwoeffectivecomponentsofthetraditionalChinesemedicineshavehighlipophilicityandareexcellentcandidatesforSLNencapsulation.Byusingthisdrugdeliverysystem,ahighbioavailabilityandanintravenousadministrationarepossible.Inthepresentstudy,SILSLNandTETSLNwerepreParedbyhighpressurehomogenization,andthephysicochemicalcharacteristicsoftheParticlesproducedbythismethodwereanalyzed.MATERIALSANDMETHODSDrugsandreagentsSIL95waspurchasedfromPanjinGreenBiologicalDevelopmentCo.Ltd.,China.TET98waspurchasedfromShanchuanBiologicalCo.Ltd.,Xian.CholesterinobtainedfromZhengxiangChemicalResearchInstitute,ShanghaiandstearicacidTiandaChemicalIndustryLtd.,TianjinwereusedseParatelyasthelipidmaterialsofSLN.SoybeanlecithinwasobtainedfromAuboxingCo.Ltd.,Beijing.Sephadexgel50waspurchasedfromTianjinChemicalIndustryLtd.MethanolHPLCgradeandabsolutealcoholwassuppliedbyXianChemicalIndustryLtd.GlycerinAmoyGlycerinIndustryLtd.wasusedasacoemulsifierinwaterphase.PreParationofSILSLNSIL75mg,cholesterin1.5gandsoybeanlecithin1.0gwereweighedpreciselywithelectronicbalanceBP121S,sartoriusLtd.,Germanyanddissolvedin10mlabsolutealcoholinwaterbathat70℃.AnaqueousphasewaspreParedbydissolving45mlglycerinin75mldistilledwater.Theresultantorganicsolutionwasrapidlyinjectedintothestirredaqueousphase80℃.Theresultingsuspensionwasstirredcontinuouslyat80℃for2h.TheoriginalSILSLNsuspensionwasthenloadedintoahighpressurehomogenizer15M8BA,APV,UK,5cyclesat50MPaandthesampleswerekeptat4℃.PreParationofTETSLNTET75mg,stearicacid1.5gandsoybeanlecithin1.0gwereweighedpreciselyandpreParedintoTETSLNsuspensionaccordingtothemethoddescribedabove.TransmissionelectronmicroscopyThemorphologyofSILSLNandTETSLNwasexaminedwithtransmissionelectronmicroscopeH600,Hitachi,JaPan.Thesampleswerestainedwith2m/Vphosphotungsticacidfor30sandplacedoncoppergridswithfilmsforviewing.MeandiameterandzetapotentialParticlecharacterizationsystemMastersizer2000,MalvernInstruments,UK,20nm2000μmandzetapotentialanalyzerZetasizerNano,MalvernInstruments,UKwereusedtostudythediameterandzetapotentialofSLNindistilledwater.ThreesamplesofSILSLN/TETSLNwerepreParedaccordingtothepreviouslydescribedmethodandeachsamplewasmeasured3timestocalculatethemeandiameterandzetapotential.EntrapmentefficiencyEEanddrugloadingDLofSILSLN.ChromatographicconditionThechromatographiccolumnofPlanetsilC184.6mm15cmwasusedwithmobilephaseofmethanol/0.1mol/Lphosphatebuffer35/65,V/V,pH3.0,flowrateof1.0ml/min,columntemperatureof40℃,anddetectionwavelengthof288nm.Thecontrolsolutions0.050,0.161,1.605,14.19,28.38,56.75,113.50μg/mlwaspreParedbydissolvingpreciselyweighedSILinthemobilephase.TheamountofSILenteringthereceptorcomPartmentwasdeterminedwithhighperformanceliquidchromatogramHPLC,LC2010,Shimadzu,JaPan.TheintegralcalculusofthechromatographicpeakareaAwasrecordedastheYaxis,andtheconcentrationofSILCastheXaxis.DrugrecoverywascalculatedfromthefollowingequationDrugrecoverymeasureddrugweightinSLN100/theoreticaldrugweightloadedinthesystem.TheSILSLNsuspensionwasseParatedbySephadexgel50columnchromatography.TheconcentrationsofSILinthesuspensionn1andfreedrugn2wereassayedbyHPLCafterdilutionwithmethanol.EEandDLcouldbecalculatedaccordingtothefollowingequationsEEn1n2/n1100,DLWdrugloadedinsystem/Wlipidmatrix100.EEandDLofTETSLNChromatographicconditionThechromatographiccolumnofSpherisorbODSC18250mm4.6mm,5μmwasusedwithmobilephaseofmethanol/ether/ethylaminevolumeproportionof10010.05andflowrateof1.0ml/minatroomtemperatureanddetectionwavelengthof282nm.Theregressionequation,percentagerecoveriesofTET,EEandDLofTETSLNweredeterminedandcalculatedaccordingtothemethodsandequationsdescribedpreviously.EvaluationofstabilitySILSLNandTETSLNwerestoredat37℃andtheParticlesizesweredeterminedafter7,45and90days,respectively,toevaluatetheirstability.StatisticalanalysisTheresultswerepresentedasMean±SD.StatisticalanalysiswasperformedusingStudentsttestwithP0.05afterstorageat37℃for90days.DISCUSSIONSLNsareacolloidalcarriersystemforcontrolleddrugdelivery,anditisclaimedthatSLNcombinestheadvantagesandavoidsthedisadvantagesofothercolloidalcarriers.Itsadvantagesincludethepossibilityofcontrolleddrugreleaseanddrugtargeting,increaseddrugstability,absenceofcarrierbiotoxicity,andlargescaleproductionandsterilization12.HighpressurehomogenizationhasemergedasareliableandpowerfultechniqueforSLNpreParation12.Inthepresentstudy,thismethodprovedtobefeasibleforpreParingSILSLNandTETSLN,whicharesmall,steadyandhighlyincorporated.ThissuccessindicatesthepossibilityofincorporatingvariouslipophiliceffectivecomponentsextractedfromthetraditionalChinesemedicinesinSLNbythismethod,whichmakepossiblehighbioavailability,controlleddrugrelease,drugtargeting,decreaseddrugtoxicitiesandminimizedsideeffects,andrepresentsasuccessfulattemptofnovelapproachtothemodernizationoftraditionalChinesemedicines.VariousfactorsmayinfluencetheParticlesizeinhighpressurehomogenization,including,forinstance,homogenizationpressure,numberofcycles,lipidsandemulsifiers/coemulsifiersused,andoperatingtemperature.Inthepresentstudy,thetwokindsofSLNwerepreParedunderidenticalconditionswithalmostthesamematerialsexceptthedrugsincorporatedinSLNandthelipidmaterial.ThedifferenceofthelipidscholesterinandstearicacidandtheinteractionsbetweenthedrugsandthelipidsmightenormouslycontributetothedifferencesofParticlesizes.However,thedetailedmechanismsremaintobefurtherinvestigated.TheshapeofSLNmaysignificantlydifferfromasphere.Lipidstendtocrystallizeintheplateletform12,13.WhatfactorscausethedifferentshapesofSLNWhichshapeisinfavorofdrugprotectionandcontrolledreleaseThesequestionshaveattractedincreasingattentioninrecentyears12,14.SilymariniscomposedmainlyofSIL,andtheextractsofmilk

注意事项

本文(高压乳匀法制备中药固体脂质纳米粒.doc)为本站会员(abingge)主动上传,人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知人人文库网([email protected]),我们立即给予删除!

温馨提示:如果因为网速或其他原因下载失败请重新下载,重复下载不扣分。

copyright@ 2015-2017 人人文库网网站版权所有
苏ICP备12009002号-5